The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
- Conditions
- Advanced Breast Cancer
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2011-12-13
- Target Recruit Count
- 2
- Registration Number
- NCT01311037
- Locations
- 🇸🇦
Kfsh & Rc, Riyadh, Saudi Arabia
Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2011-12-13
- Target Recruit Count
- 26
- Registration Number
- NCT01311011
- Locations
- 🇸🇦
Kfsh & Rc, Riyadh, Saudi Arabia
Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX
Completed
- Conditions
- Colon Cancer
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2018-08-10
- Target Recruit Count
- 6
- Registration Number
- NCT01310972
- Locations
- 🇸🇦
Kfsh & Rc, Riyadh, Saudi Arabia
Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation
Phase 1
Withdrawn
- Conditions
- Vitamin D Deficiency
- Interventions
- Drug: Placebo orally daily for 5 monthsDrug: vitamin D3 1000 IU orally daily for 5 monthsDrug: vitamin D3 3000 IU orally daily for 5 monthsDrug: vitamin D3 5000 IU orally daily for 5 months
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
- First Posted Date
- 2010-07-27
- Last Posted Date
- 2018-03-07
- Target Recruit Count
- 25
- Registration Number
- NCT01170468
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels
Not Applicable
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- Drug: placebo orally everydayDrug: ergocal1000 IU & cholecal 1000 IU orally daily
- First Posted Date
- 2010-07-27
- Last Posted Date
- 2016-08-31
- Target Recruit Count
- 279
- Registration Number
- NCT01170494
- Locations
- 🇸🇦
King Faisal Specialist Hospital & research Center, Riyadh, Saudi Arabia
Does Vitamin D Improve Glycemic Control in Type II DM?
Phase 3
Terminated
- Conditions
- Diabetes MellitusVitamin D Deficiency
- Interventions
- Drug: vitamin D3 2000 IUDrug: vitamin D3 5000 IUDrug: Placebo
- First Posted Date
- 2010-07-27
- Last Posted Date
- 2015-04-01
- Target Recruit Count
- 25
- Registration Number
- NCT01170442
- Locations
- 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca
Phase 3
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2011-12-13
- Target Recruit Count
- 260
- Registration Number
- NCT00944424
- Locations
- 🇸🇦
King Abdulaziz Hospital and Oncology Center, Jeddah, Saudi Arabia
🇸🇦King Fahad Medical City, Riyadh, Saudi Arabia
🇰🇼Kuwait Cancer Center, Kuwait City, Kuwait
Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)
Not Applicable
- Conditions
- Breast Cancer
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2011-12-13
- Target Recruit Count
- 10
- Registration Number
- NCT00544505
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
Not Applicable
- Conditions
- Ewing's Sarcoma
- First Posted Date
- 2007-10-10
- Last Posted Date
- 2012-04-17
- Target Recruit Count
- 10
- Registration Number
- NCT00541411
© Copyright 2025. All Rights Reserved by MedPath